MiR-210: A potential therapeutic target against radiation-induced enteropathy

Saad Hamama; Muhammad Zaeem Noman; Pascal Gervaz; Sylvie Delanian; Marie Catherine Vozenin

doi:10.1016/j.radonc.2013.10.030

MiR-210: A potential therapeutic target against radiation-induced enteropathy

Saad Hamama
, Muhammad Zaeem Noman
, Pascal Gervaz
, Sylvie Delanian
, Marie Catherine Vozenin^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

22 Citations (Scopus)

Abstract

A previously undescribed and robust miR210 overexpression is shown in intestinal samples obtained from patients with radiation enteropathy and fibrotic cultured cells. In addition, miR-210 overexpression is repressed by antifibrotic treatment combining pentoxifylline and α-tocopherol.

Original language	English
Pages (from-to)	219-221
Number of pages	3
Journal	Radiotherapy and Oncology
Volume	111
Issue number	2
DOIs	https://doi.org/10.1016/j.radonc.2013.10.030
Publication status	Published - May 2014
Externally published	Yes

Keywords

Anti-fibrotic treatment
Pentoxifylline
Radiation enteropathy
Radiation-induced fibrosis
Trolox
microRNA miR-210

Access to Document

10.1016/j.radonc.2013.10.030

Cite this

@article{1b0d94e182554c378cfd801cddfa8d73,

title = "MiR-210: A potential therapeutic target against radiation-induced enteropathy",

abstract = "A previously undescribed and robust miR210 overexpression is shown in intestinal samples obtained from patients with radiation enteropathy and fibrotic cultured cells. In addition, miR-210 overexpression is repressed by antifibrotic treatment combining pentoxifylline and α-tocopherol.",

keywords = "Anti-fibrotic treatment, Pentoxifylline, Radiation enteropathy, Radiation-induced fibrosis, Trolox, microRNA miR-210",

author = "Saad Hamama and Noman, \{Muhammad Zaeem\} and Pascal Gervaz and Sylvie Delanian and Vozenin, \{Marie Catherine\}",

year = "2014",

month = may,

doi = "10.1016/j.radonc.2013.10.030",

language = "English",

volume = "111",

pages = "219--221",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "Elsevier Ireland Ltd",

number = "2",

}

TY - JOUR

T1 - MiR-210

T2 - A potential therapeutic target against radiation-induced enteropathy

AU - Hamama, Saad

AU - Noman, Muhammad Zaeem

AU - Gervaz, Pascal

AU - Delanian, Sylvie

AU - Vozenin, Marie Catherine

PY - 2014/5

Y1 - 2014/5

N2 - A previously undescribed and robust miR210 overexpression is shown in intestinal samples obtained from patients with radiation enteropathy and fibrotic cultured cells. In addition, miR-210 overexpression is repressed by antifibrotic treatment combining pentoxifylline and α-tocopherol.

AB - A previously undescribed and robust miR210 overexpression is shown in intestinal samples obtained from patients with radiation enteropathy and fibrotic cultured cells. In addition, miR-210 overexpression is repressed by antifibrotic treatment combining pentoxifylline and α-tocopherol.

KW - Anti-fibrotic treatment

KW - Pentoxifylline

KW - Radiation enteropathy

KW - Radiation-induced fibrosis

KW - Trolox

KW - microRNA miR-210

UR - https://www.scopus.com/pages/publications/84902533217

U2 - 10.1016/j.radonc.2013.10.030

DO - 10.1016/j.radonc.2013.10.030

M3 - Article

C2 - 24290534

AN - SCOPUS:84902533217

SN - 0167-8140

VL - 111

SP - 219

EP - 221

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

IS - 2

ER -

MiR-210: A potential therapeutic target against radiation-induced enteropathy

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this